Liquid Biopsy in Companion Animals: What is currrent and what is on the Horizon
Teilnehmerkreis: Tierärzt:innen, vet.-med. Studierende
Zeitraum: 09.12.2026 20:00 - 21:00
Referenten:David Argyle
BVMS, PhD, DECVIM-CA (Oncology), FRSE, FRSA, FRCP (Edin), FRCVS
Zusatzinformationen:
An application for CE Hours was submitted.
Teilnahmegebühr: 57.6 €
Included in our Flatrates
Programm 09.12.2026 20:00 - 21:00
Liquid Biopsy is a minimally invasive technique to detect cancer early in dogs and cats, or to make a diagnosis. It may also be used to monitor therapy or to investigate potential relapse. This has become an increasingly high profile development area in veterinary medicine as new techniques become available, especially the detection of biomarkers in the blood or other liquid samples. This lecture will look at what is currently available and how best to access and use these techniques in clinical practice. We will also look at horizon techniques and the use of genomic medicine to make a transformational change in clinical practice. The use of multipack comics, large scale date and liquid biopsy offers a major opportunity to improve cancer outcomes.
Anmeldung:Teilnehmerbegrenzung: 1-1000 Personen
Technische Voraussetzungen: Internet
Veranstalter
vet-webinar
Argentinierstr. 43/6
1040 Wien